Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease

BACKGROUND: Kawasaki disease (KD) is usually treated with high-dose intravenous immunoglobulin (IVIg) as severe infectious and other diseases. Due to issues that are associated with immunoglobulin preparation, such as the risk of possible contamination by infectious agents and limited blood banking...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Fuyu, Oharaseki, Toshiaki, Tsukui, Daisuke, Kimura, Yoshitaka, Yanagida, Tamiko, Kishi, Fukuko, Yamakawa, Yoshio, Kameoka, Yosuke, Suzuki, Shoichi, Uno, Kazuko, Suzuki, Osamu, Miura, Noriko N., Ohno, Naohito, Takahashi, Kei, Kono, Hajime, Suzuki, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773535/
https://www.ncbi.nlm.nih.gov/pubmed/36550471
http://dx.doi.org/10.1186/s12969-022-00783-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773535/
https://www.ncbi.nlm.nih.gov/pubmed/36550471
http://dx.doi.org/10.1186/s12969-022-00783-7

Ejemplares similares